Crescent Biopharma, Inc. (CBIO) — Net Asset Momentum
Crescent Biopharma, Inc. (CBIO) recorded a net asset momentum of 1411.5% as of December 2025, with net assets of $203.01 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Crescent Biopharma, Inc. net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Crescent Biopharma, Inc. Net Asset Momentum (2011–2025)
This chart tracks Crescent Biopharma, Inc.'s year-over-year net asset growth across 15 annual reporting periods from 2011 to 2025. The most recent momentum reading is +1411.5%, with net assets of $203.01 Million USD as of December 2025. For live market cap and overall valuation, see market cap of Crescent Biopharma, Inc..
Annual Net Asset History for Crescent Biopharma, Inc. (2011–2025)
The table below shows the complete annual net asset history for Crescent Biopharma, Inc. from 2011 to 2025, covering 15 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is Crescent Biopharma, Inc.'s equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $203.01 Million | $240.29 Million | $37.28 Million | ▲ +1411.5% |
| 2024 | $-15.48 Million | $35.62 Million | $51.10 Million | ▼ -140.3% |
| 2023 | $38.41 Million | $45.32 Million | $6.90 Million | ▼ -10.5% |
| 2022 | $42.93 Million | $51.81 Million | $8.88 Million | ▼ -47.4% |
| 2021 | $81.60 Million | $94.35 Million | $12.74 Million | ▼ -36.4% |
| 2020 | $128.22 Million | $142.83 Million | $14.61 Million | ▼ -16.8% |
| 2019 | $154.20 Million | $167.97 Million | $13.77 Million | ▼ -25.0% |
| 2018 | $205.46 Million | $214.84 Million | $9.38 Million | ▲ +71.6% |
| 2017 | $119.70 Million | $128.58 Million | $8.88 Million | ▲ +239.1% |
| 2016 | $35.30 Million | $42.39 Million | $7.09 Million | ▼ -12.8% |
| 2015 | $40.47 Million | $48.46 Million | $7.99 Million | ▼ -20.3% |
| 2014 | $50.80 Million | $57.26 Million | $6.46 Million | ▲ +1647.4% |
| 2013 | $2.91 Million | $5.28 Million | $2.38 Million | ▼ -76.8% |
| 2012 | $12.53 Million | $18.42 Million | $5.89 Million | ▲ +48.1% |
| 2011 | $8.46 Million | $28.91 Million | $20.45 Million | — |